Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases.
- nov 2014
- Esther de Vries
- 1
- 3239
ARTIKEL: Verstegen RH, Borte S, Bok LA, van Zwieten PH, von Döbeln U, Hammarström L, de Vries E. J Allergy Clin Immunol. 2014 Apr;133(4):1208-11.
Bijlagen
| titel | toegevoegd | door | opties | |
|---|---|---|---|---|
| Verstegen_et_al_JACI.pdf | nov 2014 |  |
Verken
Decreased response after conjugated meningococcal serogroup C vaccination in children with down syndrome.
nov 2014ARTIKEL: Kusters MA, Jol-Van Der Zijde EC, Gijsbers RH, de Vries E. Pediatr Infect Dis J. 2011 Sep;30...
Functionality of the pneumococcal antibody response in Down syndrome subjects.
nov 2014ARTIKEL: Kusters MAA, Manders NCC, de Jong BAW, van Hout RWNM,RijkersGT, de Vries E. Vaccine. 2013 Dec...
Significant impact of recurrent respiratory tract infections in children with Down syndrome.
nov 2014ARTIKEL: Verstegen RH, van Gameren-Oosterom HB, Fekkes M, Dusseldorp E, de Vries E, van Wouwe JP. Chil...